Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ammonium Salt Sulfisoxazole
2. Diolamine, Sulfisoxazole
3. Gantrisin
4. Gantrisin Pediatric
5. Monolithium Salt Sulfisoxazole
6. Monosodium Salt Sulfisoxazole
7. Neoxazoi
8. Pediatric, Gantrisin
9. Sulfadimethyloxazole
10. Sulfafurazol Fna
11. Sulfafurazole
12. Sulfasoxizole
13. Sulfisoxazole
14. Sulfisoxazole, Ammonium Salt
15. Sulfisoxazole, Monolithium Salt
16. Sulfisoxazole, Monosodium Salt
17. Sulfisoxazole, Monosodium, Monomesylate Salt
18. Sulfisoxazole, Triammonium Salt
19. Tl Azole
20. Tl-azole
21. Triammonium Salt Sulfisoxazole
22. V Sul
23. V-sul
1. 4299-60-9
2. Sulfafurazole Diolamine
3. Sulfafurazol 2,2'-imidodiethanol
4. Sulfisoxazole Diolamine [usan]
5. Sulphafurazole Diolamine
6. Sulfisoxazole Diolamine [usan:usp]
7. Nu-445
8. Sulfafurazole Diethanolamine
9. Sulfisoxazole (diethanolamine)
10. 30s4b46j8b
11. Gantrisin (tn)
12. N(sup 1)-(3,4-dimethyl-5-isoxazolyl)sulfanilamide Compound With 2,2'-iminodiethanol (1:1)
13. Benzenesulfonamide, 4-amino-n-(3,4-dimethyl-5-isoxazolyl)-, Compd. With 2,2'-iminobis(ethanol) (1:1)
14. Sulfisoxazole Diolamine (usan)
15. 4-amino-n-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide;2-(2-hydroxyethylamino)ethanol
16. Einecs 224-308-1
17. Unii-30s4b46j8b
18. Sulfisoxazoldiolamin
19. Sulfisoxazole Diethanolamine
20. N-(3,4-dimethylisoxazol-5-yl)sulphanilamide, Compound With 2,2'-iminodiethanol (1:1)
21. Schembl23466
22. Chembl1200321
23. Chebi:88263
24. Hy-b0323a
25. Dtxsid90195616
26. Sulfafurazole Diolamine [mart.]
27. Sulfisoxazole Diolamine [vandf]
28. Sulfisoxazole Diethanolamine Salt
29. Cs-0030851
30. Sulfafurazole Diethanolamine [who-dd]
31. Sulfisoxazole Diolamine [orange Book]
32. Sulfisoxazole Diethanolamine Salt [mi]
33. D05957
34. Q27160153
35. 4-amino-n-(3,4-dimethyl-1,2-oxazol-5-yl)benzene-1-sulfonamide--2,2'-azanediyldi(ethan-1-ol) (1/1)
| Molecular Weight | 372.4 g/mol |
|---|---|
| Molecular Formula | C15H24N4O5S |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 372.14674105 g/mol |
| Monoisotopic Mass | 372.14674105 g/mol |
| Topological Polar Surface Area | 159 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 402 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
ABOUT THIS PAGE
99
PharmaCompass offers a list of Sulfisoxazole Diolamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulfisoxazole Diolamine manufacturer or Sulfisoxazole Diolamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulfisoxazole Diolamine manufacturer or Sulfisoxazole Diolamine supplier.
PharmaCompass also assists you with knowing the Sulfisoxazole Diolamine API Price utilized in the formulation of products. Sulfisoxazole Diolamine API Price is not always fixed or binding as the Sulfisoxazole Diolamine Price is obtained through a variety of data sources. The Sulfisoxazole Diolamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sulfisoxazole Diolamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulfisoxazole Diolamine, including repackagers and relabelers. The FDA regulates Sulfisoxazole Diolamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulfisoxazole Diolamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulfisoxazole Diolamine supplier is an individual or a company that provides Sulfisoxazole Diolamine active pharmaceutical ingredient (API) or Sulfisoxazole Diolamine finished formulations upon request. The Sulfisoxazole Diolamine suppliers may include Sulfisoxazole Diolamine API manufacturers, exporters, distributors and traders.
Sulfisoxazole Diolamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulfisoxazole Diolamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulfisoxazole Diolamine GMP manufacturer or Sulfisoxazole Diolamine GMP API supplier for your needs.
A Sulfisoxazole Diolamine CoA (Certificate of Analysis) is a formal document that attests to Sulfisoxazole Diolamine's compliance with Sulfisoxazole Diolamine specifications and serves as a tool for batch-level quality control.
Sulfisoxazole Diolamine CoA mostly includes findings from lab analyses of a specific batch. For each Sulfisoxazole Diolamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulfisoxazole Diolamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulfisoxazole Diolamine EP), Sulfisoxazole Diolamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulfisoxazole Diolamine USP).
